UBS ETF USA SRI CHF A logo

UBS ETF USA SRI CHF A (0HDR)

Market Closed
LSE LSE
CHF
CHF
4.41B Market Cap
3.72% Div Yield
- Volume
CHF
Previous Close
Day Range
0 0
Year Range
0 0
Want to track 0HDR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

0HDR is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on LSE (CHF).

0HDR Chart

Similar

UU
United Utilities Group PLC
1,348 GBX
+0.52%
Investment AB Öresund
kr 133.4
-0.45%
Halyk Savings Bank of Kazakhstan JSC
$ 20.25
0%
Amundi Italy BTP Government Bond 1-3Y UCITS ETF Dist
104.78
+0.24%
JPMorgan Global Growth & Income Fund
580 GBX
-0.85%

UBS ETF USA SRI CHF A (0HDR) FAQ

What is the stock price today?

The current price is 0.00 CHF.

On which exchange is it traded?

UBS ETF USA SRI CHF A is listed on LSE.

What is its stock symbol?

The ticker symbol is 0HDR.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 3.72%.

What is its market cap?

As of today, the market cap is 4.41B.

Has UBS ETF USA SRI CHF A ever had a stock split?

No, there has never been a stock split.

UBS ETF USA SRI CHF A Profile

LSE Exchange
US Country

Overview

Groupe Bruxelles Lambert SA, established in 1902, is a renowned investment company based in Brussels, Belgium. It focuses on acquiring significant holdings in a diverse range of industrial, consumer goods, and business service companies. With operations stretching from Belgium to various European countries, North America, and internationally, the company has a broad geographic footprint. Its investment approach is characterized by a strategic selection of companies operating across different sectors, aiming to generate sustainable returns. Groupe Bruxelles Lambert SA structures its operations through seven distinct segments: Holding, Imerys, Webhelp, Canyon, Affidea, Sanoptis, and GBL Capital and Sienna Investment Managers, each catering to specific market needs and sectors.

Products and Services

  • Holding

    This segment involves the strategic management and administration of the company’s investments, focusing on long-term value creation and maintaining a diversified investment portfolio.

  • Imerys

    Through its Imerys segment, Groupe Bruxelles Lambert SA invests in a world leader specialized in mineral-based specialty solutions for industry. Imerys provides a wide range of products that contribute to improving the performance of its clients' products and processes.

  • Webhelp

    Webhelp represents the company’s investment in a global leader in business process outsourcing (BPO), particularly in customer experience and payment services. This segment leverages technology and human expertise to deliver exceptional customer engagement and business solutions.

  • Canyon

    The Canyon segment consists of investments in companies leading in their respective fields, focusing on sectors such as technology, media, telecommunications, and healthcare, aiming to drive innovation and growth.

  • Affidea

    Affidea is a leading provider of advanced diagnostic imaging, outpatient, and cancer care services. GBL's investment in Affidea underscores its commitment to healthcare excellence and accessible patient care.

  • Sanoptis

    Through Sanoptis, Groupe Bruxelles Lambert SA invests in a network of eye clinics and practices, emphasizing quality eye care services. This includes preventative eye health as well as advanced treatments and surgeries.

  • GBL Capital and Sienna Investment Managers

    This segment is dedicated to the company's asset management activities, offering innovative investment solutions and strategies to institutions, family offices, and high-net-worth individuals globally.

Contact Information

Address: Avenue Marnix 24, Brussels, Belgium, 1000
Phone: 32 2 289 17 17